Provided by Tiger Trade Technology Pte. Ltd.

iShares Core High Dividend ETF

27.83
-0.1270-0.45%
Volume:1.02M
Turnover:28.30M
Market Cap:14.57B
PE:- -
High:27.93
Open:27.90
Low:27.82
Close:27.96
52wk High:30.13
52wk Low:23.52
Shares:523.60M
Float Shares:523.60M
Volume Ratio:1.39
T/O Rate:0.19%
Dividend:0.85
Dividend Rate:3.06%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

New York Fed President Anticipates Lower Energy Costs to Help Curb Overall Inflation

Deep News
·
Jul 07

Market Sentiment Shifts from Enthusiasm to Prudence: Asian Tech Stocks Face a Samsung Earnings Test, Prompting Rotation to Financial and Defensive Sectors

Stock News
·
Jul 07

How To Earn $500 A Month From Citigroup Stock Ahead Of Q2 Earnings

Benzinga Earnings
·
Jul 06

3 ASX Dividend Stocks Yielding Up To 8%

Simply Wall St.
·
Jul 06

iShares Core High Dividend ETF announces Q2 2026 distribution of R$ 0.06 per unit

Reuters
·
Jun 23

iShares Core High Dividend ETF BDR to pay BRL 0.06 per unit dividend on June 24

Reuters
·
Jun 23

iShares Core High Dividend ETF declares monthly distribution of R$ 0.34 per unit

Reuters
·
Jun 19

iShares Core High Dividend ETF BDR sets dividend at USD 0.98 per share

Reuters
·
Jun 18

Assembly Biosciences Announces Upcoming Investor Conference Presentations

GlobeNewswire
·
May 29

Aligos Therapeutics Presents Positive Data at the EASL Congress 2026

GlobeNewswire
·
May 27

Press Release: Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Dow Jones
·
May 27

FDA approves Gilead’s Hepcludex injection to treat chronic HDV infection

TIPRANKS
·
May 23

Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases

GlobeNewswire
·
May 22

Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference

GlobeNewswire
·
May 11

Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights

GlobeNewswire
·
May 08

Mirum’s brelovitug succeeds in Phase 2b HDV trial

TIPRANKS
·
Apr 27